March 2015 – FDA issues Drug Safety Communication

Announcement Date: March 3, 2015

March 3, 2015 – FDA issues a Drug Safety Communication stating that “prescription testosterone products are approved only for men who have low testosterone levels caused by certain medical conditions.”